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ABSTRACT
In the last few years nucleotide receptors, the ionotropic P2X1-7 subunits and
the metabotropic P2Y1, 2, 4, 6, 11, 12, 13, 14, have acquired an excepcional importance due
to their strategic location in organs and tissues, their great variety along with the
complexity of the associated signalling pathways and the first evidence of the
serious alterations entailed in their dysfunctions. Our group has been pioneer in
the characterization of these receptors in the nervous system, where we defined
their location and functionality. The abundant presence, at a presynaptic level, of
P2X3 and P2X7 should be emphasized, where by means of calcium intake they
induce neurotransmitter exocytosis, such as glutamate, GABA, catecholamines and
acetylcholine among others, as described in previous works by our group. In addi-
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tion, they induce an extensive remodeling of the terminal’s cytoskeleton and exo-
cytotic mechanisms through CaMKII and they can interact widely with other io-
notropic and metabotropic receptors co-existing in nearby areas. Neural cells also
exhibit the presence of most P2Y receptors signalling through a large variety of
intracellular cascades. Recently we have demostrated that P2Y metabotropic re-
ceptors of the sub-family activated by ADP, especially P2Y13, are connected with
the signalling towards GSK3 and β-catenin, opening new ways of understading the
nucleotide function in survival and maintenance of neural cells. In addition both
P2X and P2Y receptors play a role in early developmental stages and neural ma-
turation where their function has to be fully understanded. Nucleotide receptors
are also very abundant in glial cells, and our group has shown that most P2Y
receptors are present and fully functional in cultured astrocytes, where, depending
on the subtype receptor they activate a large variety of signalling cascades.
Key words: ionotropic P2X receptors, metabotropic P2Y receptors, central
nervous system, ATP, synaptic terminals, neurotransmitters release.
RESUMEN
Papel fisiológico de los nucleótidos extracelulares en el sistema nervioso
central: señalización vía receptores P2X y P2Y.
En los últimos años los receptores de nucleótidos, receptores ionotrópicos
P2X1-7 y metabotrópicos P2Y1, 2, 4, 6, 11, 12, 13, 14, han adquirido una importancia excep-
cional debido a su localización estratégica en órganos y tejidos, a su gran variedad
junto con la complejidad de vías de señalización a las que están asociados y a las
primeras evidencias de importantes alteraciones debidas a su mal funcionamiento.
Nuestro grupo ha sido pionero en la caracterización estos receptores en el sistema
nervioso, donde definimos su localización y su funcionalidad. La abundante pre-
sencia, a nivel presináptico, de las subunidades P2X3 y P2X7 debe ser resaltada,
donde gracias a la entrada de calcio inducen la exocitosis de varios neurotransmi-
sores, como glutamato, GABA, catecolaminas y acetilcolina entre otros, como ha
sido descrito por nuestro grupo en trabajos previos. Además, estos receptores in-
ducen una profunda remodelación del citoesqueleto de las terminales nerviosas y
de los mecanismos exocitóticos a través de la CaMKII y pueden interactuar con
otros receptores ionotrópicos y metabotrópicos co-existentes en sus cercanías. La
mayoría de los receptores P2Y también están presentes en las células nerviosas,
activando vías de señalización a través de una gran variedad de cascadas intrace-
lulares. Recientemente hemos demostrado que los receptores metabotrópicos P2Y
pertenecientes a la sub-familia de receptores activados por ADP, especialmente el
P2Y13, están conectados con la señalización hacia GSK3 y β-catenina, lo que abre
nuevas vías para la comprensión de la función de los nucleótidos en la superviven-
cia y el mantenimiento de las células nerviosas. Además, tanto los receptores P2X
como los P2Y juegan un papel en los estadíos iniciales del desarrollo y en la
maduración neuronal donde su función aún ha de ser plenamente comprendida.
Los receptores de nucleótidos son también muy abundantes en las células gliales,
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y nuestro grupo ha demostrado que la mayoría de los receptores P2Y están presen-
tes y son plenamente funcionales en astrocitos en cultivo, donde, dependiendo del
subtipo de receptor, activan una gran variedad de cascadas de señalización.
Palabras clave: receptores ionotrópicos P2X, receptores metabotrópicos P2Y,
sistema nervioso central, ATP, terminales sinápticas, liberación de neurotransmi-
sores.
INTRODUCTION
The wide distribution and the discovery of new and multiple
actions of nucleotides in organs and tissues, through membrane
receptors named P2 purinergic receptors, have aroused a lot of
interest in investigating their cellular biology, the type of
dysfunctions associated with the excess or defect of nucleotide
signalling, and the search and design for reliable agonists and
antagonists that can be used in pharmacology. In the last two years
we have assisted to the growing progress in the number of
publications related to nucleotide signalling and its physio-
pathological implications, which gives evidence of its therapeutic
potential in a near future. Between the increasing numbers of
revisions, we have selected those written by Professor G. Burnstock,
by their historical meaning and seminal contributions (1-3). The
prestigious journal Trends in Pharmacological Sciences, com-
memorated the 75th anniversary of the British Pharmacological
Society foundation with the publication of a special volume, in which
the revision of Burnstock entitled «ATP as a neurotransmitter» (4),
is included as one of the 6 most relevant and historical revisions. 36
years ago, Pharmacological Reviews published an article entitled
«Purinergic Nerves» (5) that first laid the foundations of purinergic
neurotransmission, but that finding was scarcely attractive to the
scientific community at that time.
The extracellular role of ATP, or any other nucleotide, requires
the presence of this compound outside the cell. In this way, the
presence of ATP and other nucleotides and dinucleotides in a large
variety of storage and secretory vesicles, such as the cholinergic and
aminergic ones, from neural or neuro-endocrine tissues, or the ones
from platelets and mastocytes, suggested an extracellular role, as co-
transmitter, or extracellular functions for nucleotides (6). The
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vesicular storage and exocytotic release of nucleotides with other
neurotransmitters is now well established, and the kinetic properties
of the granular and vesicular nucleotide transporter, exhibiting a
characteristic mnemonic regulation, have been studied by our group
(7, 8). However, the extracellular signalling mediated by ATP and
nucleotides is so broadly extended, that other mechanisms for
nucleotide release should exist. For a non-quantal, or non Ca2+
dependent exocytotic release, numerous membrane proteins have
been postulated such as some members of the ABC transporter
family, members of the ecto-ATPase family known as CD-39, or
connexins hemichannels, and constitutes a fertile area of debate and
research (9).
The physiological effects of extracellular nucleotides conclude by
the action of ectonucleotidases, rendering phosphate and the
nucleosides. The broad variety and abundance of these enzymes in
all studied cells have made difficult the study of nucleotide receptors
responses (10).
NUCLEOTIDE RECEPTOR FAMILIES
The nucleotide receptors are grouped in two big families, the
ionotropic, known as P2X, and metabotropic, called P2Y.
Metabotropic P2Y family
The metabotropic P2Y family contains 8 members, P2Y1,2,4,6,11,12,13,14
receptors. Due to their variety they are trying to divide them in three
families, essentially depending on the G protein with which they
couple preferentially, and the nature of the nucleotide agonist. This
way we have the P2YA group coupled to Gq and Gs and which prefer
adenine nucleotides (P2Y1 and P2Y11). The next group is P2YB,
coupled to Gq and Gi/o, which can recognize both uridine and
adenosine nucleotides (P2Y2, P2Y4, P2Y6). The P2YC group, couple
essentially to Gi and recognize with great efficiency ADP (P2Y12,
P2Y13), while P2Y14 is activated by UDP-glucose. Attempts to assign
other members to the P2Y family have been rejected (11). The effects
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of P2Y receptors in different signalling pathways are interconnected
and it requires to be analyzed from an integrated point of view (12).
It should be emphasized the great contributions by the group of K.
Harden, E. Barnard, J.M. Boeynaems, J.T. Neary, M.P. Abbracchio
and more recently J.P. Gachet among others (13-16). Recent
evidences of homo- and heterodimerization of nucleotide receptors
have been reported. This fact provides new possibilities of signalling
and new pharmacological approaches (17). The family of metabo-
tropic P2Y receptors exhibits a very abundant presence in all neural
and glial cells, where more than one subtype co-exists. The
physiological nucleotide agonists of P2Y receptors are very diverse,
some of them such as P2Y1,12,13 are specific for ADP, P2Y11 is the only
one specific for ATP, others as P2Y2, P2Y4, and P2Y6 are activated
mainly by the pyrimidine nucleotides UTP and UDP. These
metabotropic receptors are coupled to G proteins and activate a
large variety of downstream cascades, such as PI3K, AKT, MAP
kinases, and recently it has been reported the glycogen synthase
kinase-3, GSK3, regulation. Glial cells, exhibit a broad diversity of
functional P2Y receptors, coupled to Gq or Gi proteins and signalling
to intracellular cascades related to survival and proliferation. Figure
1 shows the main signalling cascades described for the P2Y subtypes
and Table 1 summarises the agonists, antagonists and G proteins
coupling of the P2Y receptors subtypes.
As described for other seven helix G protein coupled receptors,
the possibility of P2Y metabotropic receptors forming homodimers
or heterodimers increases the signalling and modulation posibilities
and should be considered in the future (18).
Ionotropic P2X family
P2X ionotropic receptor family contains a total of seven subunits,
P2X1,2,3,4,5,6,7.  They present simple structures, with only two
transmembrane helixes, internal amine and carboxy terminals and a
large extracellular domain where the nucleotide binding site is
located. It is widely accepted, although not completely demonstrated,
that a minimum of three subunits are required to obtain a functional
ionotropic receptor. As in most of the studied tissues more than one
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subunit is expressed, it is probably that the majority of P2X receptors
are heteromeric in nature (18). Unlike P2Y, these P2X receptors only
recognize adenine nucleotides, in concentrations able to be reached
in physiological conditions.
FIGURE 1. Signal transduction mechanisms of P2Y receptors. In general, P2Y
receptors are coupled, through G protein, to PLC, and induce intracellular calcium
mobilization, and finally, PKC activation. In addition, P2Y activation can induce
other signalling mechanisms such as PLD, PLA2, MAPK and NOS activation.
Moreover, P2Y receptors can be coupled to AC through Gi proteins
and to potassium and calcium channels.
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The properties and functional characterization of homomeric and
heteromeric receptors built with the P2X subunits was carried out
by a broad number of scientific groups, and will still require
extensive experimental work (19-25). Recently the P2X7 receptor has
deserved a special attention, not only due to the existence of
polymorphisms and the pronostic of chronic myeloid leukaemia
(CML) in humans and immune system functions, but also due to
recent data of a possible role in other aspects of neuronal functioning
(26-28). For this reason, P2X7 has become a preferential target for
pharmaceutical enterprises (29).
From an electrophysiological point of view, all P2X receptors are
cation selective ligand gated ion channels, with permeability similar
for Na+ and K+, but very high for Ca2+, depending on the implicated
subunits. It is probable that an excess intake of calcium through
these receptors could contribute in vivo to pathologies associated
with P2X receptors (25, 30-36). P2X subunits are formed by two
transmembrane domains with intracellular N and C termini and a
large extracellular ligand binding loop connecting them (Figure 2).
Functional receptors require the assembling of at least three subunits
to form homomeric or heteromeric receptors. It was generally
accepted that P2X7 exclusively formed homomeric receptors,
although recent data points to a coasembling almost with PX4 (37).
The main physiological agonist of functional P2X receptors is ATP,
and for the moment there is a limited battery of nucleotide synthetic
agonists to pharmacologically identify each one of the homomeric or
heteromeric P2X combinations. The same situation occurs with the
antagonist’s disponibility, as it can be seen in Table 2. In spite of
this situation, combination of diverse nucleotide agonists and
antagonists, together with the kinetic behaviour exhibiting or not
desensitization allows the identification of different P2X functional
receptors. Molecular biology and immunohistochemical techniques
are relevant tools to confirm the tissular and cellular location of the
P2X receptor subunits.
M.ª TERESA MIRAS-PORTUGAL Y COLS. ANAL. REAL ACAD. NAC. FARM.
1136
T
A
B
L
E
 2
.
C
h
a
ra
ct
er
is
ti
cs
 o
f 
P
2
X
 h
o
m
o
m
er
ic
 p
u
ri
n
o
ce
p
to
rs
R
ec
ep
to
r
P
2X
1
P
2X
2
P
2X
3
P
2X
4
A
g
o
n
is
ts
A
T
P
=
2M
eS
A
T
P
≥A
p
6A
≥α
, β
-m
eA
T
P
>
B
zA
T
P
>
A
D
P
A
T
P
≥A
T
P
γS
≥M
eA
T
P
>
A
p
4A
α
, 
β-m
eA
T
P
 y
 A
D
P
in
ac
ti
ve
s
2M
eS
A
T
P
≥A
T
P
=
α
,β-
m
eA
T
P
>
A
p
5
A
>
A
D
P
A
T
P
>
2M
eS
A
T
P
α
, 
β-m
eA
T
P
 y
 A
D
P
in
ac
ti
ve
s
P
o
te
n
ti
at
io
n
 b
y
Iv
er
m
ec
ti
n
,
P
ro
p
o
fo
l 
an
d
 C
ib
ac
ro
n
b
lu
e
A
n
ta
g
o
n
is
ts
N
F
44
9>
T
N
P
-A
T
P
>
Ip
5
I
>
M
R
S
22
57
>
P
P
A
D
S
 (
n
M
)
S
u
ra
m
in
>
R
B
 2
 (
μM
)
R
B
 2
=
N
F
27
9,
 N
F
77
0
>
P
P
A
D
S
=
T
N
P
-A
T
P
=
B
B
G
≥S
u
ra
m
in
 (
μM
)
T
N
P
-A
T
P
>
M
R
S
22
57
=
A
31
74
91
>
M
R
S
21
59
=
P
P
A
D
S
 (
n
M
)N
F
27
9=
N
F
44
9>
Ip
5I
≥S
u
ra
m
in
>
N
F
02
3>
R
B
 2
 (
μM
)
A
31
74
91
, 
N
F
11
0,
p
h
en
o
l 
re
d
T
N
P
-A
T
P
>
B
B
G
 (
μM
)
p
h
en
o
lp
h
th
al
ei
n
Io
n
m
o
d
u
la
ti
o
n
H
+
↓
Z
n
2+
↓
H
+
↑
Z
n
2+
↑
C
u
2+
↑
C
a2
+
↑
Z
n
2+
↑
H
+
↓
C
a2
+
↑
H
+
↓
Z
n
2+
↑
C
d
2
+
↑
D
es
en
si
-
ti
za
ti
o
n
F
as
t
S
lo
w
F
as
t
S
lo
w
M
a
jo
r
d
is
tr
ib
u
ti
o
n
B
ra
in
, 
sp
in
a
l 
c
o
rd
,
sm
o
o
th
 
m
u
sc
le
, 
p
la
te
-
le
ts
, 
sy
m
p
at
h
et
ic
 g
an
gl
ia
B
ra
in
, 
sp
in
a
l 
c
o
rd
,
sm
o
o
th
 m
u
sc
le
, 
sy
m
p
a-
th
et
ic
 
ga
n
gl
ia
, 
ch
ro
m
a-
fi
n
 c
el
ls
, 
re
ti
n
a
B
ra
in
, 
sp
in
a
l 
c
o
rd
,
sm
o
o
th
 
m
u
sc
le
, 
sy
m
-
p
at
h
et
ic
 g
an
gl
ia
, 
se
n
so
ry
n
eu
ro
n
s
B
ra
in
, 
sp
in
a
l 
c
o
rd
,
sm
o
o
th
 
m
u
sc
le
, 
sy
m
-
p
at
h
et
ic
 
ga
n
gl
ia
, 
te
st
is
,
co
lo
n
VOL. 73 (4), 1127-1157, 2007 PHYSIOLOGICAL ROLE OF EXTRACELLULAR...
1137
T
A
B
L
E
 2
.
C
h
a
ra
ct
er
is
ti
cs
 o
f 
P
2
X
 h
o
m
o
m
er
ic
 p
u
ri
n
o
ce
p
to
rs
(c
o
n
t.
)
R
ec
ep
to
r
P
2X
5
P
2X
6
P
2X
7
A
g
o
n
is
ts
A
T
P
=
2M
eS
A
T
P
=
A
p
4A
>
α
, 
β-m
eA
T
P
>
B
zA
T
P
A
D
P
 i
n
ac
ti
ve
2M
eS
A
T
P
≥A
T
P
=
α
,β-
m
eA
T
P
>
A
p
5
A
>
A
D
P
B
zA
T
P
>
2M
eS
A
T
P
>
>
A
T
P
α
,β-
m
eA
T
P
 a
n
d
 A
D
P
in
ac
ti
ve
A
n
ta
g
o
n
is
ts
P
P
A
D
S
>
T
N
P
-A
T
P
>
S
u
ra
m
in
>
R
B
 2
 (
μM
)
T
N
P
-A
T
P
>
P
P
A
D
S
S
u
ra
m
in
 i
n
se
n
si
ti
ve
A
-7
40
03
=
A
-4
38
07
9
(r
at
, 
h
u
m
an
)
B
B
G
 (
n
M
) 
(r
at
)
P
P
A
D
S
=
T
N
P
-A
T
P
 (
n
M
)
K
N
-6
2 
(n
M
)
(h
u
m
an
, 
m
o
u
se
)
S
u
ra
m
in
 (
m
M
)
(r
at
, 
h
u
m
an
)
D
es
en
si
-
ti
za
ti
o
n
S
lo
w
S
lo
w
F
as
t
M
a
jo
r
d
is
tr
ib
u
ti
o
n
T
ri
ge
m
in
u
s 
ga
n
gl
ia
, 
sp
i-
n
a
l 
c
o
rd
, 
p
ro
li
fe
ra
ti
-
ve
 
sk
in
 
ce
ll
s,
 
th
ym
u
s,
b
la
d
d
er
B
ra
in
, 
sp
in
a
l 
c
o
rd
,
sy
m
p
at
h
et
ic
 g
an
gl
ia
R
et
in
al
 g
an
gl
ia
, 
im
m
u
n
e
ce
ll
s,
 b
ra
in
, 
sp
in
al
 c
o
rd
,
sk
in
, 
p
an
cr
ea
s.
M.ª TERESA MIRAS-PORTUGAL Y COLS. ANAL. REAL ACAD. NAC. FARM.
1138
FIGURE 2. Transmembrane topology and oligomeric structure of P2X recep-
tors. The intracellular N- and C-termini, two transmebrane domains (M1 and M2)
and the extracellular ligand-binding loop are shown. Conservatives cysteines
residues, organized in two domains (C1 and C2), and the glycosilation sites are
indicated. Moreover, in the extracellular loop is shown the conserved positively
charged residues (K68 and K309) involved in the ATP binding. In addition, the
model of oligomerization proposed for P2X receptors is shown. Transmembrane
helixes II are participating mainly in the channel formation.
PRESENCE AND FUNCTION OF P2X RECEPTORS IN
SYNAPTIC TERMINALS
Synaptic terminal studies allowed us to identify the presynaptic
ionotropic receptors that responded specifically to ATP and some
more specific agonists and antagonists, and even link them with the
presence of P2X subunits through immunohistochemistry. The
results obtained point to a coexistence in a single synaptic terminal
of different types of P2X and dinucleotide receptors (38-42).
Considering the great variety of synaptic terminals it is important
to characterize in what types P2X receptors are preferentially found.
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Currently we can characterize the responses in specific terminals
after functional studies, using immunohistochemical techniques. The
presynaptic ionotropic nucleotide receptors are functional and very
abundant in cholinergic terminals, identified with double dye with
the vesicle acetylcholine transporter (VAT) (43), also in GABAergic
terminals characterized by the presence of the inhibitor aminoacids
transporter (VIAAT) or of the neural isoform of glutamate
descarboxylase (GAD65) (44, 45). Similar abundance of ionotropic
nucleotide receptors is observed in aminergic terminals in striatum,
characterized by the presence of monoamine vesicular transporter
(VMAT-2). We should emphasize its equally abundant presence in
glutamatergic terminals, detected by immunohistochemistry of the
vesicular glutamate transporter, both the types 1 and 2 (46, 47).
It could be thought that in an analogous way we could
characterize the terminals that store ATP and dinucleotides in their
vesicles but for the moment the nucleotide vesicular transporter has
not been cloned and only kinetically characterized (8, 48).
Immunocytochemical studies have proven that P2X subunit
distribution in synaptic terminals is notoriously different than those
present in neural soma, but for the moment it is not known how a
preferential location and distribution is accomplished, and
expression tests have not been yet made in polarized cells that
can serve as a model. In previous work from our group it has
been reported that P2X3 subunit is very abundant in CNS terminals
and that all of the synaptic terminals responding to α−β-methylen-
ATP and ATP where afterwards immunolabeled with anti-P2X3
antibodies (49). Besides, there are terminals that respond to
nucleotides and do not present staining for this subunit. Recently we
have reported that P2X7 subunit is also present in great abundance
in CNS terminals, other authors have also found this location in
peripheral nerves (42, 50-53). More than 50% of isolated synaptic
terminals from diverse areas of central nervous system exhibit
P2X7 receptors both by immunostaining and microfluorimetric
techniques. Thus, all the signalling mediated by this receptor
acquires a special relevance in the synaptic degenerative processes
(54) and should deserve special attencion in the future. Figure 3
shows the preferential distribution of some P2X at the synaptic
terminals.
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P2X receptors from the presynaptic area are able to induce
calcium dependent exocytotic release upon stimulation. The
nucleotide effect is dose dependent and the induced release of
classical neurotransmitters such as: acetylcholine, glutamate, GABA
FIGURE 3. Experimental based distribution of P2X receptors in CNS. P2X
receptors exhibit a specific distribution along the axodendritic fibres (A). P2X1
(red) and P2X4 (green) are preferently located at the dendrites and somas. P2X3
(yellow) and P2X7 (pink) are mainly at the axons. P2X2 subunit expression (blue)
is restricted to the somas. The activation of the different P2X receptors produces
an increase in intracellular calcium levels and activates different signalling mecha-
nisms.
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or catecholamines has been reported (55-61). Figure 4 shows the
exocytotic release from rat midbrain synaptic terminals, after
stimulation. It can be observed that the quantity of neurotransmitter
released by mg of protein from synaptosomal preparation mirrors
the relative abundance of eah specific type of terminal, being
glutamatergic the most abundant. The dose response curves reported
in Figure 4 have been obtained with ATP in the presence of Mg2+ ion
and correspond in a great extent to secretion mediated by P2X3
presynaptic receptors. Later the secretory responses mediated by
P2X3 compared to P2X7 will be reported in cultured granule neurons.
Presynaptic ionotropic receptors functionality is something that
has recently appeared and very insistently, as the mean to regulate
in a drastic way the secretory capacity of terminals and essentially
all ionotropic receptors described in neural soma have been now
characterized in the neural secreting area (55-63). This could be the
case for NMDA, AMPA, GABAA and especially nicotinic and,
nucleotidic neural receptors wich role on the control of synaptic
terminals secretion, synaptic plasticity, recovery and stability, or long
term depression or potentiation, has to be settled (57, 58, 60, 61, 64-
FIGURE 4. P2X receptor activation induces glutamate, GABA and
acetylcholine release from presynaptic terminals. Synaptic terminals isolated
from rat midbrain were stimulated with increasing ATP concentrations. The
amount of glutamate and GABA in the extrasynaptosomal media were measured
by HPLC. Extrasynaptosomal acetylcholine was quantified by the luminometric
protocol described by Israel and Lesbats (85).
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66). The presence at the presynaptic level of a large variety of
ionotropic and metabotropic receptors suggests the possibility of
multiple interactions and cross-talk, an attempt to understand some
of them is described in next paragraph.
INTERACTION OF P2X AND OTHER IONOTROPIC AND
METABOTROPIC RECEPTORS AT THE PRESYNAPTIC
LEVEL
Ionotropic receptors interaction
Previous publications from our group reported the coexistence of
ionotropic ATP and dinucleotide receptors with neuronal nicotinic
receptors (41, 60), both being functional when are separatedly
stimulated. This fact posses a series of questions: 1) whether a
synergism between them exists, maybe leading to an exhaustion of
the terminals, 2) whether they exclude each other and to what extent,
and 3) whether their own subunits interacts with each other. This
last possibility has been outlined in an interesting work by Khakh et
al. (67), in which they show that the coexpression of ATP homomeric
P2X2 and acetylcholine receptors, nicotinic α3-β4 in oocytes, interfere
mutually in the ion intake responses. If this happens in particular
terminals it is something important, since α3, α4 and α7 nicotinic
subunits have been involved, when they are located at a presynaptic
level, in Alzheimer’s disease, and constitute nowadays a preferential
target in the new pharmacology to alleviate said disease. This is only
an example of how complex are the interactions between different
ionotropic receptors, in which nucleotide receptors widely
participate, and that beyond this complexity it is necessary to
undertake, if we pretend to understand how is actually functioning
the presynaptic area.
The specific situation of nicotinic and nucleotidic ionotropic
receptors colocalizing at the same terminal exhibits relevant
functional characteristics, because the activation of nicotinic
receptors inhibits in a high extent the ionotropic P2X, and
dinucleotide receptors calcium responses. This reduction in the
calcium entrance also results in a decrease in the acetylcholine
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release induced by nucleotides. What is the mechanism responsible
for the effect? This is a question with relevant physiological
implications. In our experimental model of cholinergic synaptic
terminals the inhibitory effect of nicotinic receptors on P2X receptors
appears to be mediated by the activation of Calcium calmoduline
kinase II, CaMKII, as this enzyme becomes activated by the
intrasynaptosomal calcium increase upon receptor activation. The
key role played by this enzyme in nerve terminals is confirmed by
using the enzyme inhibitor KN62 wich completely prevents the
inhibitory effect induced through nicotinic receptors agonists. This
undoubtedly will allow us to take another step in the synaptic
knowledge and avoid over-stimulation (60, 68). Figure 5 sumarises
the modulation of P2X receptors by ionotropic (nicotinic) and
metabotropic (GABAB) receptors.
Ionotropic nucleotide receptors modulation by metabotropic
receptors
Presynaptic ionotropic nucleotide receptors are also under the
influence of a large variety of metabotropic receptors located in the
presynaptic area. To this respect we have described dramatic effects
caused by protein kinase and phosphatase action, when they are
directly activated or inhibited, or through a more physiological way
of presynaptic receptors stimulation. The receptor’s affinity for their
nucleotide agonists can be decreased in situations where kinase
activity is increased, both by cAMP dependent kinases, PKA, or
members of the PKC family (69). The oposite situation also occurs
and an inhibition of protein kinases, or agonistic action on Gi
coupled metabotropic receptors, results in a bigger affinity of P2X
receptors, and also an increase in calcium maximal response. There
are remarkable examples such as those reported for A1 adenosine
receptors, and also GABAB receptors, both coupled to Gi. In the
presence of these receptors agonists, the affinity values of nucleotides
for P2X are increased in 3-5 orders of magnitude, going from mM
to nM or pM (70). An especial mention should be given to GABAB
receptors, since they are ubiquitous in CNS and especially at a
presynaptic level, given the abundance of nucleotide signalling and
presence of P2X3 subunits in GABAergic terminals, the study of the
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modulation of P2X receptors by GABA metabotropic receptors can
give a clue to understand neuropathic pain, in which insufficient
GABAB signalling has been involved (55, 57, 59). Although the A1
adenosine and GABAB receptors are among the most abundant
located at a presynaptic level, the presence and effect of other Gi
coupled receptors among the dopamine family (D2, D3, D4) and
glutamatergic metabotropic family (group II and group III) should
be explored in specific brain areas.
PRESENCE AND FUNCTION OF P2 RECEPTORS IN
CULTURED NEURONS
In previous works by our group we proved that P2Y metabotropic
receptors can coexist with P2X ionotropic receptors in neurons, like
Purkinje, neurochromaffin cells from adrenal medulla and in
cerebellar granule neurons (52, 71-74). In endothelial cells and
FIGURE 5. P2X receptor modulation by ionotropic and metabotropic recep-
tors. A) Co-existence of nicotinic and P2X receptors. Agonistic effect on acetylcho-
line nicotinic receptors induces intracellular calcium increase, activation of
CaMKII and as a result inhibition of P2X responses in calcium entrance. B) Co-
existence of metabotropic GABAB and P2X receptors. Agonistic effect on GABAB
receptors coupled to Gi results in an affinity and calcium increase mediated by
P2X receptors agonists.
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astrocytes multiple subtypes of P2Y receptors coexist. One of the
first references about this coexistence is our group’s work in vascular
endothelial cells (75). One data of extreme complexity that can reach
the nucleotide signalling system in neuronal cells is proved by the
presence in cerebellar granular neurons in culture, of most of the
P2Y and P2X receptors cloned so far, furthermore, with preferentially
somatic or axonic/dendritic distribution depending on the receptor
subtype (51, 52). The presence of P2 receptors and their function has
also been studied in neuroblastoma and other tumoral cell lines
from neural origin, where the expression of diverse members of P2Y
and P2X family has also been shown. The complex neural
architecture is also an element to keep in mind concerning the
toxicity, stress and neurodegeneration aspects, since the topographic
distribution of P2X and P2Y receptors is extremely complex and
could generate different responses in neural maintenance and
recuperation. Cerebellar granule neurons have been extensively
studied by our group and a brief summary concerning the presence
and signalling of P2X and P2Y is reported below.
Presence and function of P2X receptors from cultured
cerebellar granule neurons
The presence, distribution and function of P2X receptors have
been extensively studied in the experimental model of cultured
granule neurons obtained from young mice cerebellum. The relative
expression levels of P2X receptors have been analysed by real time
PCR, at 9 div, the most abundant are: P2X4, P2X7, P2X3, P2X2, and
P2X1, and by that order. The mRNA levels correlate well with the
Western blot protein levels, detected with specific antibodies (76).
Microfluorimetric techniques to study the calcium responses with
specific P2X agonists and antagonists show the presence of
functional receptors, being P2X7 and P2X3 the ones most relevant at
the axodendritic fibers, in agreement with their immunocytochemical
localization. Both receptors are able to induce calcium entrance and
calcium dependent exocytotic release, in this case due to the
glutamatergic nature of granule cells, the released neurotransmitter
is glutamate. The intracellular calcium increase also results in
cytoskeletal reorganization mediated by activation of the calcium
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calmoduline kinase II, CaMKII. This enzyme phosphorylates
synapsin allowing the approaching of neurosecretory vesicles to the
docking secretory areas of the presynaptic plasma membrane (61,
77). Figure 6 shows cultured granule neurons loaded with Fura-2
responding to the P2X7 agonist, and to a massive depolarization
induced by K+ ion, to compare the magnitude of both events.
FIGURE 6. ATP effect on cultured granule neurons from mouse cerebellum.
A) Cultured neurons (9 days in vitro) were stimulated with ATP 600 μM for 30
seconds. At the end of the experiment cells were stimulated with KCl to asses its
neuronal nature. B) Microphotographs of the granule neurons at t = 0 s (1);
t = 15 s, during ATP stimulation (2); t = 60 s, before ATP stimulation (3);
t = 140 s, during the masive depolarization induced by KCl (4); t = 200 s, in the
presence of the perfussion medium. The axodendritic fibres that respond to ATP
and to KCl are shown in yellow. The arrow point a responding fibre to ATP.
Scale bar = 5 μm.
Presence and function of P2Y receptors from cultured
cerebellar granule neurons
Cerebellar granule neurons exhibit a great heterogeneity in
nucleotide responses when studies in single cell are carried out.
These responses concern both the ionotropic and metabotropic
responses of P2X and P2Y receptors. These responses all became
modified during the course of granule cells differentiation, not only
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at the level of the number of responding cells but also in the
magnitude of the response to nucleotides (51). These in vitro
developmental changes were more significant in metabotropic
responses to pyrimidine nucleotides, UTP and UDP, which were
down and up regulated respectively, during the time in culture. These
changes correlated with changes in the mRNA expression levels for
P2Y4 and P2Y6 receptors.
P2Y1 receptor is present in almost all, if not all, granule neurons
when single cell microfluorimetric experiments are carried out, and
cells challenged with 2MeSATP, that is a full synthetic agonist of this
receptor. In most cells the calcium responses are completely
inhibited, or significantly reduced, in the presence of MRS2179, that
is the best antagonist of P2Y1 available. The mRNA expression and
the presence of the protein measured by western blot, for P2Y1
receptor, increases with time in culture, but in a more moderate way
compared with the P2Y4 and P2Y6 receptors.
In addition to P2Y1, the presence of P2Y12 and P2Y13 has been
recently reported in granule neurons, all of them being members of
the ADP responding nucleotide receptors. Thus the metabotropic
cascades activated by ADP require to be carefully studied to properly
asignate the function to one of the receptors families. Recently our
group has found that Glycogen synthase kinase-3 (GSK-3) a
multifaceted enzyme involved in development, neurogenesis, and
survival at the CNS was induced to phosphorylation and subsequent
inhibition of its catalytic activity by 2-methyl-thio-ADP (2MeSADP).
This compound could be acting through several P2Y-ADP receptors
expressed in granule neurons, as RT-PCR expression was found
for P2Y1, P2Y12 and P2Y13 receptors. As the effect on GSK-3
phosphorylation was sensitive to pertussis toxin and was unaffected
by specific antagonists of P2Y1 and P2Y12 receptors, such as
MRS2179 and 2-methyl-thio-AMP, respectively, the pharmacological
data fitted well with a Gi-coupled P2Y13 receptor. The signalling
cascade from P2Y13 after activation through 2MeSADP is relatively
complex as it was able to phosphorylate and activate extracellular
signal-regulated kinase (ERK)-1,2 and Akt proteins, but its effect on
GSK-3 phosphorylation was primarily dependent on the phosphatidyl
inositol-3 kinase (PI3-K)/Akt pathway, as it was abolished by the PI3-
K inhibitor wortmannin. GSK-3 inactivation by 2MeSADP in granule
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neurons resulted in nuclear translocation of its substrate β-catenin,
which functions as a transcriptional regulator, this effect being lost
with wortmaninn (78). Figure 7 summarises the signalling cascade
from P2Y13 to GSK-3 and nuclear β-catenin. Now, further work is
necessary to understand the physiological meaning of this signalling
pathway in CNS development, maintenance and senescence.
PRESENCE AND FUNCTION OF P2 RECEPTORS IN
CULTURED ASTROCYTES
Cultured astrocytes from rat cerebellum express almost all the
P2Y receptors described so far, and there are also evidence for the
presence and peculiar functionality of some P2X receptors.
The mRNA expression was studied by PCR and presence of
P2Y1,2,4,6,11,12,13 metabotropic nucleotide receptors was detected. At the
same time and if specific antibodies were available, studies of
immunocytochemistry or western blot were accomplished. Not
always the presence of mRNA corresponded with protein detection
by western blot or immunocytochemistry, or later on with functional
responses from astrocytes. For example, P2Y1 receptor correlates
well the mRNA expression, protein detection and cellular responses,
but that is not the case for P2Y12 receptor that in spite of mRNA
presence, there was no specific labelling of astrocytes with anti-
P2Y12 receptor antibody, whereas a specific staining was observed,
as positive control in platelets.
Studies of the P2X subunits expression was carried out by RT-
PCR techniques. In these assays high levels of mRNA codifying for
P2X1, P2X3, P2X4 and P2X7 subunits were detected. In contrast, P2X2,
P2X5 and P2X6 subunits appeared to be nearly absent in astrocytes
cultures. In most cases the mRNA detection does not correlate with
the presence of the protein. In fact, by immunocytochemistry using
specific antibodies only P2X4 and P2X7 subunits were detected. These
data are relevant because it is possible that P2X7 and P2X4 form
functional hetero-oligomers (37) in cerebellar astrocytes.
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FIGURE 7. A) Signalling pathways activated by 2MeSADP in cerebellar granule
neurons. 2MeSADP, activating a P2Y13 receptor, induces an increase in GSK-3
phosphorylation and inhibition of its catalytic activity. This phosphorylation
occurs through a PI3K/Akt-dependent pathway. The lack of activity of GSK-3
towards its substrate β-catenin avoids its phosphorylation and degradation, and
allows its translocation to the nucleus, where it functions as a transcriptional
regulator. B) Immunostainnig of the main P2Y-ADP receptors expressed in
cerebellar granule neurons, P2Y1 and P2Y13 receptors. C) Fluorescence images
of β-catenin immunostaining in cerebellar granule neurons that were stimulated
for 10 minutes with 1 μM 2MeSADP. The increase in β-catenin levels induced by
2MeSADP treatment was maintained in presence of the specific antagonist of P2Y1
receptor, MRS-2179.
P2Y functional responses in astrocytes
Calcium responses measured using fura-2 microfluorimetric
techniques suggest that different P2Y subtypes could be responsible
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for ATP metabotropic calcium responses in single type 1 astrocytes.
All tested astrocytes responded to ATP and UTP stimulations evoking
similar calcium transients. Most astrocytes also responded to 2-
MeSADP and ADP challenges. The agonist potency and cross-
desensitization experiments demonstrated the presence of functional
P2Y1 and P2Y2 or P2Y4 receptors. In addition, the existence of an
astrocyte subpopulation that express functional P2Y6 was de-
monstrated, this accounting for 30-40% of the total.
In addition to phospholiphase C activation, PLC, and subsequent
calcium increase from internal stores, P2Y1,2,4,6 receptors, can also
activate the ERKs signalling cascade as they increase in western blot
the phosphorylated forms of ERK1 and ERK2 (79).
P2X functional responses in astrocytes
Recent data from our group support the presence of functional
ionotropic P2X7 nucleotide receptors in cerebellar astrocytes.
Although both P2X4 and P2X7 receptors were expressed at the protein
level, the responses found with the specific agonist BzATP are in
agreement with the activation of a P2X7 type, which exhibits a
distinctive behaviour in astrocytes. BzATP-induced calcium increases
are sustained, and not transient, as those obtained with the
metabotropic agonists 2MeSADP or UTP and far from inducing cell
lysis as described for P2X7 receptors from macrophages. Moreover,
stimulation of P2X7-like receptor induces significant morphological
changes in astrocytes and leads to differentiation (84).
CONCLUSIONS
Nucleotide receptors are very abundant at the central nervous
system, in all types of neural cells. Their physiological roles are far
from being elucidated and only fragmentary data are available.
However, there are increasing evidence concerning their involvement
in neuropathogenesis due to aging and neurotrauma. The specific
distribution and signalling cascades asociated with their neuronal
location, as soma, dendritic or axonal subcellular distribution, should
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be considered to analyse in depth their physiological function, the
possible diseases asociated to their disfuction and the pharma-
cological perspectives for their specific agonists and antagonists.
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